{
    "code": "02022354",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022354",
    "time": "2018-08-31 04:26:32",
    "許可證字號": "衛署藥輸字第022354號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/12\/15",
    "發證日期": "87\/12\/15",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202235401",
    "中文品名": "克立生注射劑〝麥森艾佛特〞",
    "英文品名": "CLEXANE INJECTION",
    "適應症": "治療深部靜脈血栓、與ＡＳＰＩＲＩＮ併用以治療不穩定狹心症及非Ｑ波之急性心肌梗塞。適用於年齡75歲以下，腎功能（Ccr）大於60 ml\/min，ST-波段升高的急性心肌梗塞的病患，不論患者隨後是否接受冠狀動脈血管成形術，皆可與血栓溶解劑併用",
    "劑型": "270注射劑",
    "包裝": "注射針筒",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "ENOXAPARINSODIUM"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1424601100  賽諾菲股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F150086100  Sanofi Winthrop Industrie",
        "製造廠廠址": "180 RUE JEAN-JAURES B.P. 40 94702 MAISONS ALFORT CEDEX FRANCE15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE",
        "製造廠公司地址": "15,RUE DE LA VANNNE,92120-MONTROUGE,FRANCE"
    },
    "CCC號列": "30019010002 肝素及其鹽類Heparin and its salts",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F150247100  SANOFI AVENTIS France",
            "製造廠廠址": "82, AVENUE RASPAIL 94250 GENTILLY FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "6000.0000000000",
            "單位": "ANTI-XA IU"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "8000.0000000000",
            "單位": "ANTI-XA IU"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2012401610",
            "成分名稱": "ENOXAPARIN SODIUM",
            "含量描述": "",
            "含量": "10000.0000000000",
            "單位": "ANTI-XA IU"
        }
    ],
    "仿單外盒": [
        {
            "title": "Clexane 0.6ml_LPI_C_CCDS v13_TFDA comment 2017.07.14 clean-106-08-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022354&Seq=042&Type=9"
        },
        {
            "title": "020223540012.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022354&Seq=012&Type=8"
        }
    ]
}